[1]马福军,钱 征.胃十二指肠吻合术、胃空肠吻合术、胃空肠Roux-en-Y式吻合术治疗胃癌疗效及安全性分析[J].陕西医学杂志,2022,51(6):729-732,748.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.021]
　MA Fujun,QIAN Zheng.Efficacy and safety of Billroth Ⅰ,Billroth Ⅱ and Roux-en-Y anastomosis in treatment of gastric cancer[J].,2022,51(6):729-732,748.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.021]
点击复制

胃十二指肠吻合术、胃空肠吻合术、胃空肠Roux-en-Y式吻合术治疗胃癌疗效及安全性分析
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
51
期数:
2022年6期
页码:
729-732,748
栏目:
临床研究
出版日期:
2022-06-05

文章信息/Info

Title:
Efficacy and safety of Billroth Ⅰ,Billroth Ⅱ and Roux-en-Y anastomosis in treatment of gastric cancer
作者:
马福军; 钱 征
(西安国际医学中心医院消化外科,陕西 西安 710100)
Author(s):
MA Fujun; QIAN Zheng
(Department of Digestive Surgery,Xi'an International Medical Center Hospital,Xi'an 710100,China)
关键词:
胃癌;  胃十二指肠吻合术;  胃空肠吻合术;  胃空肠Roux-en-Y式吻合术;  疗效;  安全性
Keywords:
Gastric cancer;  Gastroduodenostomy;  Gastrojejunostomy;  Gastrojejunostomy Roux-en-Y anastomosis;  Curative effect;  Safety
分类号:
R 735.2
DOI:
DOI:10.3969/j.issn.1000-7377.2022.06.021
文献标志码:
A
摘要:
目的:探讨胃十二指肠吻合术(Billroth Ⅰ)、胃空肠吻合术(Billroth Ⅱ)、胃空肠Roux-en-Y式吻合术(Roux-en-Y)治疗胃癌的疗效及安全性。方法:回顾性分析行胃癌根治术后消化道重建的80例患者的临床资料,以术后重建方式不同分为B-Ⅰ组(21例)、B-Ⅱ组(29例)及R-Y组(30例)。比较三组围手术期指标(手术时间、术中出血量和住院时间)、术后恢复指标[术后排气时间、术后进食时间和预后营养指数(PNI)]、胃功能指标(胃管拔除时间、胃排空时间和血浆胃动素水平)以及并发症发生情况。结果:B-Ⅰ组手术时间及术中出血量显著少于B-Ⅱ组和R-Y组,而B-Ⅱ组手术时间及术中出血量显著少于R-Y组(均P<0.05)。B-Ⅱ组术后排气时间、术后进食时间及PNI显著大于B-Ⅰ组和R-Y组(均P<0.05),但B-Ⅰ组与R-Y组术后排气时间、术后进食时间及PNI比较差异无统计学意义(均P>0.05)。B-Ⅱ组胃排空时间显著多于B-Ⅰ组和R-Y组,血浆胃动素水平显著低于B-Ⅰ组和R-Y组(均P<0.05),但B-Ⅰ组与R-Y组胃排空时间及血浆胃动素水平比较差异无统计学意义(均P>0.05)。R-Y组反流性食管炎、胆汁反流、残胃炎发生率显著低于B-Ⅰ组与B-Ⅱ组(均P<0.05),但B-Ⅰ组与B-Ⅱ组反流性食管炎、胆汁反流、残胃炎发生率比较差异无统计学意义(均P>0.05)。B-Ⅰ组吻合口瘘发生率显著高于B-Ⅱ组与R-Y组(均P<0.05),但B-Ⅱ组与R-Y组吻合口瘘发生率比较差异无统计学意义(P>0.05)。结论:Billroth Ⅰ术式操作简单,手术时间短; Billroth Ⅱ术式无明显优势,临床运用较少; Roux-en-Y术式则是较为理想的重建方式,能有效避免术后胃肠道功能性并发症。
Abstract:
Objective:To explore the efficacy and safety of gastroduodenostomy(Billroth Ⅰ),gastrojejunostomy(BillrothⅡ)and gastrojejunostomy Roux-en-Y anastomosis(Roux-en-Y)in the treatment of gastric cancer.Methods: The clinical data of 80 patients with digestive tract reconstruction after radical gastrectomy were retrospectively analyzed.The patients were divided into B-Ⅰ group(21 cases)and B-Ⅱ group(29 cases)and R-Y group(30 cases)according to the different postoperative reconstruction methods.Perioperative indexes(operative time,intraoperative blood loss and hospital stay),postoperative recovery indexes(postoperative exhaust time,postoperative feeding time and PNI),gastric function indexes(gastric tube removal time,gastric emptying time and plasma motilin level)and complications were compared among the three groups.Results:The operation time and intraoperative blood loss in B-Ⅰ group were significantly less than those in B-Ⅱ and R-Y group,while the operation time and intraoperative blood loss in B-Ⅱ group were significantly less than those in R-Y group(all P<0.05).The postoperative exhaust time,postoperative feeding time and PNI in B-Ⅱ group were significantly higher than those in B-Ⅰgroup and R-Y group(all P<0.05),but there was no significant difference in postoperative exhaust time,postoperative feeding time and PNI between B-Ⅰ group and R-Y group(all P>0.05).The gastric emptying time of B-Ⅱ group was significantly higher than that of B-Ⅰgroup and R-Y group,and the plasma motilin level was significantly lower than that of B-Ⅰ group and R-Y group(all P<0.05),but there was no significant difference in gastric emptying time and plasma motilin level between B-Ⅰ group and R-Y group(all P>0.05).The incidence of reflux esophagitis,bile reflux and residual gastritis in R-Y group was significantly lower than that in B-Ⅰ group and B-Ⅱ group(all P<0.05),but there was no significant difference in the incidence of reflux esophagitis,bile reflux and residual gastritis between B-Ⅰ group and B-Ⅱ group(all P>0.05).The incidence of anastomotic leakage in B-Ⅰ group was significantly higher than that in B-Ⅱ group and R-Y group(all P<0.05),but there was no significant difference between B-Ⅱ group and R-Y group(P>0.05).Conclusion:BillrothⅠ is easy to operate and short in operation time.Billroth Ⅱ has no obvious advantages and is less clinically used.Roux-en-Y is an ideal reconstruction method,which can effectively avoid postoperative gastrointestinal functional complications.

参考文献/References:

[1] 宫之奇,李泽群,薛伟杰,等.不同吻合器在腹腔镜远端胃癌根治术Roux-en-Y式吻合中的安全性及卫生经济学对比[J].腹腔镜外科杂志,2020,25(3):203-208.
[2] 谭玉成,徐建庆.腹腔镜根治术对胃癌患者肿瘤标志物及氧化应激水平的影响[J].陕西医学杂志,2021,50(8):969-972.
[3] 左婷婷,郑荣寿,曾红梅,等.中国胃癌流行病学现状[J].中国肿瘤临床,2017,44(1):52-58.
[4] 黄昌明,林建贤.全腹腔镜胃癌根治术规范化实施策略与技术难点[J].中国实用外科杂志,2016,36(9):925-928.
[5] 王小林,马任远,张 哲.腹腔镜手术治疗老年进展期胃癌50例临床疗效分析[J].陕西医学杂志,2019,48(10):1360-1362.
[6] 徐泽宽,徐 皓,王林俊.全腹腔镜胃癌根治术消化道重建方式的选择及技术要点[J].中华消化外科杂志,2017,16(3):227-230.
[7] 陈海飞,钱 旭,张 易,等.全腹腔镜远端胃癌根治术消化道重建Billroth-Ⅰ式、Billroth-Ⅱ式及Roux-en-Y吻合对比研究[J].现代肿瘤医学,2020,28(7):1152-1156.
[8] 梁 寒.胃癌远端胃切除术后消化道重建手术方式的选择及临床评价[J].中华消化外科杂志,2016,15(3):216-220.
[9] Virgilio E,Balducci G,Mercantini P,et al.Reconstruction after distal gastrectomy for gastric cancer:Billroth 2 or Roux-en-Y procedure?[J].Anticancer Research,2017,37(10):5595-5602.
[10] Zhu Z,Shan X,Cheng Y,et al.Clinical course of diabetes after gastrectomy according to type of reconstruction in patients with concurrent gastric cancer and type 2 diabetes[J].Obesity Surgery,2015,25(4):673-679.
[11] 高聪聪,范 筱,李 宁.益气健脾化积方对胃癌化疗疗效、患者安全性及预后影响的研究[J].陕西中医,2019,40(4):475-477.
[12] 尹克宁.腹腔镜远端胃癌根治术中三角吻合与Billroth Ⅰ吻合的效果对比[J].中国现代普通外科进展,2019,22(2):130-132.
[13] 胡 祥.腹腔镜远端胃癌根治术BillrothⅠ式消化道重建——全腔镜下还是小切口辅助[J].中华胃肠外科杂志,2015,18(8):770-771.
[14] Huang C,Lin M,Chen Q,et al.A modified intracorporeal Billroth-Ⅰ anastomosis after laparoscopic distal gastrectomy for gastric cancer:A safe and feasible technique[J].Annals of Surgical Oncology,2015,22(1):247.
[15] 王正江,韩 靓,秦 毅,等.结肠镜在胃大部切除Billroth-Ⅱ式吻合术后胆总管结石取石中的应用[J].中华肝胆外科杂志,2017,23(z1):483-485.
[16] 黄昌明,林 密.全腔镜下进行BiIIrothⅠ式消化道重建[J].中华胃肠外科杂志,2015,18(8):771-772.
[17] 王 黔,陈家驹,杨弘鑫,等.4K腹腔镜远端胃癌根治术Roux-en-Y吻合消化道重建[J].中华消化外科杂志,2020,19(z1):85-87.
[18] 黄玉琴,史友权,汤 东,等.非离断式Roux-en-Y吻合术在远端胃癌根治术后消化道重建的应用进展[J].中华消化外科杂志,2016,15(9):943-946.
[19] 刘 洋,孟 化,李梦伊,等.食管空肠π形Roux-en-Y吻合术在全腹腔镜全胃切除术中的应用价值[J].中华消化外科杂志,2018,17(6):626-630.
[20] 张维汉,吴春成,宋小海,等.远端胃癌切除术不同消化道重建方式术后恢复指标和术后一年上消化道内镜评估结果的比较[J].中华胃肠外科杂志,2016,19(2):216-220.
[21] 杨年钊,方华进,张义胜,等.胃癌远端胃切除术后Roux-en-Y与Billroth Ⅱ消化道重建术的比较研究[J].实用医学杂志,2015,31(24):4110-4115.
[22] 赵民学,叶洪珊,朱 琳,等.老年胃癌患者改良Roux-en-Y吻合58例[J].中国老年学杂志,2015,35(6):1687-1688.

相似文献/References:

[1]侯洁心 ,郭萍△.免疫组化标志物Her2和肿瘤标志物在胃癌诊断中的价值分析*[J].陕西医学杂志,2019,(1):121.
　HOU Jiexin,GUO Ping..The value of immunohistochemical marker Her2 andtumor markers in the diagnosis of gastric cancer[J].,2019,(6):121.
[2]唐亚荣.循环热灌注化疗联合替吉奥及热疗治疗老年胃癌癌性腹水临床研究*[J].陕西医学杂志,2019,(4):435.
　TANG Yarong..Clinical effect analysis of combined therapy with tiago and hyperthermia in the treatment of malignant ascites in elderly patients with gastric cancer[J].,2019,(6):435.
[3]刘国庆,闫 龙△,高 任.1.5T磁共振扩散加权成像在胃癌淋巴结转移诊断中的应用价值*[J].陕西医学杂志,2019,(4):456.
　LIU Guoqing,YAN Long,GAO Ren..1.5T magnetic resonance diffusion weighted imaging in the diagnosis of lymph node metastasis of gastric cancer[J].,2019,(6):456.
[4]胡乃军,王海龙.胃腺癌组织中MMP11、MMP12和VEGFD的表达及临床意义[J].陕西医学杂志,2019,(5):554.
[5]米志宽,赵菊梅.抑癌基因甲基化与胃癌关系研究进展*[J].陕西医学杂志,2019,(5):679.
　MI Zhikuan,ZHAO Jumei..Research progress of relationships between tumor suppressor gene methylation and gastric cancer[J].,2019,(6):679.
[6]石颖鹏,王敏娟,李程亮.肠化生相关分子与胃癌的发生和进展研究概况[J].陕西医学杂志,2019,(7):958.
　SHI Yingpeng,WANG Minjuan,LI Chengliang,et al.Intestinal metaplasia-related molecules and the occurrence and progress of gastric cancer[J].,2019,(6):958.
[7]郭小艳,于桂萍.抗幽门螺杆菌疗法联合新辅助化疗对胃癌术后疗效及患者血清VEGF、bFGF的影响[J].陕西医学杂志,2019,(8):1010.
　GUO Xiaoyan,YU Guiping..Effect of anti-Helicobacter pylori therapy combined with neoadjuvant chemotherapy on serum VEGF and bFGF in postoperative patients with gastric cancer[J].,2019,(6):1010.
[8]柯东平,毛俊倩,郭甲民,等.SCNN1B与胃癌细胞上皮间质转化相关性实验研究*[J].陕西医学杂志,2019,(9):1115.
　KE Dongping,MAO Junqian,GUO Jiamin,et al.Research on the correlation between SCNN1B and〖JZ〗 epithelialmesenchymal transformation in gastric cancer cells[J].,2019,(6):1115.
[9]王小林,马任远,张 哲.腹腔镜手术治疗老年进展期胃癌50例临床疗效分析[J].陕西医学杂志,2019,(10):1360.
[10]刘维帅,郭晓宁,杨 洋,等.胃癌病理类型及临床预后与血清miR-133a和DKK-1相关性分析[J].陕西医学杂志,2020,49(6):751.[doi:DOI:10.3969/j.issn.10007377.2020.06.028]
　LIU Weishuai,GUO Xiaoning,YANG Yang,et al.Correlation of pathological types and clinical prognosis of gastric cancer with serum miR-133a and DKK-1[J].,2020,49(6):751.[doi:DOI:10.3969/j.issn.10007377.2020.06.028]

备注/Memo

备注/Memo:
基金项目:陕西省重点研发计划项目(2019SF-046)
更新日期/Last Update: 2022-06-06